first glp 1 approval Navigating the -tides: Medication-Assisted Weight Loss on the Forefront GLP-1R Agonists for Weight Loss
Description
Wegovy injection or tablets: In patients with diabetes mellitus, monitor blood glucose before starting and during therapy

The Medicare GLP-1 Bridge launched July 1, 2026, offering $50/month copays for eligible Part D beneficiaries through December 2027
Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing

Dual GIP-GLP1-receptor agonists in the treatment of type 2 diabetes: a short review on emerging data and therapeutic potential

Despite some studies showing cases of cancer development, the numbers reported are as minimal as one case
